Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Tampa General Hospital

Tampa, Florida 33606, United StatesNot linked to an institution yet

96running trials
39closed trials

The trials here

What the 137 trials at this site are about, from their registry records.

Conditions: Childhood cancers52 trials
Acute lymphoblastic leukaemia13 trials
Heart failure13 trials
Sarcoma11 trials
Colorectal cancer10 trials
Stroke10 trials
Acute myeloid leukaemia8 trials
Kidney cancer8 trials
Neuroblastoma7 trials
Ovarian cancer7 trials
Coronary artery disease5 trials
Aortic aneurysm4 trials
and 38 more
Phase: Phase 343 trials
Phase 223 trials
Phase 1/25 trials
Phase 13 trials
Phase 2/32 trials
Early phase 11 trial
Phase 41 trial
Status: Active, not recruiting51 trials
Recruiting35 trials
Completed33 trials
Not yet recruiting8 trials
Terminated4 trials
Enrolling by invitation2 trials
Suspended2 trials
Withdrawn2 trials
Lead sponsor: Children's Oncology Group32 trials
National Cancer Institute (NCI)20 trials
University of South Florida7 trials
Alliance for Clinical Trials in Oncology5 trials
Abiomed Inc.4 trials
and 57 more

Running trials

Not yet recruiting
Starting HIV Prevention Medicine (PrEP) During an Emergency Department Visit With a Peer Navigator
NCT07901101· Phase 4· University of South Florida· Source
Contact: Bernice K McCoy, PhD, MPH
Recruiting
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
NCT06965504· Abiomed Inc.· Source
Contact: Courtney Nicholas, BS RN, CCRP, CVRN-BC
Not yet recruiting
Randomized Clinical Trial of the Application of TrachPhone HME and the Impact on Patient Satisfaction for Tracheostomized Head and Neck Cancer Patients
NCT07798414· Phase 1/2· University of South Florida· Source
Contact: Jennifer T Larsson, MS, CCC-SLP
Not yet recruiting
A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.
NCT06458907· P+F Products + Features USA Inc.· Source
Contact: Thuy Olender
Not yet recruiting
A First-in-Human Feasibility Study of the Vibrant Stroke Detection Technology During Carotid Endarterectomies
NCT07851389· Vibrant Medical Ltd.· Source
Contact: Charles Briggs, MD (principal investigator)
Recruiting
Pacritinib Effectiveness in Real-world Settings
NCT07774455· Swedish Orphan Biovitrum· Source
Contact: Gesiotto
Recruiting
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
NCT07215910· Phase 3· Alliance for Clinical Trials in Oncology· Source
Contact: Sajeel A. Chowdhary (principal investigator)
Recruiting
NORM-HF Pivotal Study
NCT07574593· Foundry Innovation & Research 1, Limited (FIRE1)· Source
Contact: Troy Penz
Recruiting
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
NCT07428616· Phase 2· Exelixis· Source
Contact: Exelixis Clinical Trials
Recruiting
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
NCT07232030· CVRx, Inc.· Source
Contact: Courtney Nicholas
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
NCT07285655· Phase 3· Liquidia Technologies, Inc.· Source
Contact: Elisabeth Ballans
Recruiting
Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy
NCT07419490· University of South Florida· Source
Contact: Jennifer Childress, RN, CCRP
Active, not recruiting
Intravascular Neuro OCT Imaging System for Aneurysm Treatment Evaluation
NCT07214220· Spryte Medical· Source
Active, not recruiting
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
NCT07340320· Phase 2· Corxel Pharmaceuticals· Source
Enrolling by invitation
SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study
NCT07116668· SafeHeal Inc· Source
Recruiting
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
NCT07078383· Vascutek Ltd.· Source
Contact: Clinical Research Nurse
Recruiting
Breaking Fasts Ahead of Cardiac Caths
NCT06996639· University of South Florida· Source
Contact: Samip Vasaiwala, MD
Enrolling by invitation
Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery
NCT07050485· University of South Florida· Source
Active, not recruiting
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
NCT06735534· Boston Scientific Corporation· Source
Recruiting
Alleviant ALLAY-HFrEF Study
NCT06812533· Alleviant Medical, Inc.· Source
Contact: Jason Feliberti, MD (principal investigator)
Not yet recruiting
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
NCT06887673· Early phase 1· University of South Florida· Source
Contact: Avennette Pinto
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
NCT06513962· Phase 3· Children's Oncology Group· Source
Contact: Andrew J. Galligan (principal investigator)
Recruiting
StrokeNet Thrombectomy Endovascular Platform
NCT06289985· Medical University of South Carolina· Source
Contact: Jordan Elm
Recruiting
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
NCT06699212· Phase 3· Rakuten Medical, Inc.· Source
Contact: Monica Rengifo Pardo
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
NCT06578247· Phase 3· Daiichi Sankyo· Source
Recruiting
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
NCT06504589· Nicole Hamblett· Source
Contact: Andrew Marino
Active, not recruiting
A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer
NCT05154487· Phase 2· GOG Foundation· Source
Recruiting
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
NCT06319963· Phase 1/2· Theravectys S.A.· Source
Contact: Noman Ashraf, MD (principal investigator)
Active, not recruiting
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
NCT06137807· P+F Products + Features USA Inc.· Source
Active, not recruiting
A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias
NCT06226571· Phase 1· Syndax Pharmaceuticals· Source
Recruiting
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
NCT02998229· Medtronic Neurovascular Clinical Affairs· Source
Contact: Muni Sai Bachalakuri
Recruiting
Complex Aneurysm Registry - Real-World Evidence Data Collection for Intracranial Aneurysm Treatment Devices
NCT06215105· Microvention-Terumo, Inc.· Source
Contact: Shalini Nampally
Recruiting
Zenith® Fenestrated+ Clinical Study
NCT04875429· Cook Research Incorporated· Source
Contact: Dean Arnaoutakis, MD
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
NCT05929768· Phase 3· SWOG Cancer Research Network· Source
Contact: Victoria Rizk (principal investigator)
Active, not recruiting
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
NCT05602194· Phase 3· Children's Oncology Group· Source
Recruiting
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
NCT05812807· Phase 3· Alliance for Clinical Trials in Oncology· Source
Contact: Sara Tolaney, MD
Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
NCT05675410· Phase 3· National Cancer Institute (NCI)· Source
Contact: Andrew J. Galligan (principal investigator)
Active, not recruiting
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
NCT05478304· AtriCure, Inc.· Source
Active, not recruiting
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation and Continuing Response
NCT05610163· Phase 2/3· Alliance for Clinical Trials in Oncology· Source
Active, not recruiting
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
NCT05047172· Phase 3· University of Florida· Source
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
NCT05174169· Phase 2/3· NRG Oncology· Source
Contact: Boris Naraev (principal investigator)
Active, not recruiting
A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor
NCT04939597· Phase 3· Children's Oncology Group· Source
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
NCT05040360· Phase 2· SWOG Cancer Research Network· Source
Contact: Boris Naraev (principal investigator)
Active, not recruiting
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755· Medtronic Cardiovascular· Source
Active, not recruiting
Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer
NCT05228275· Children's Oncology Group· Source
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
NCT05235165· Phase 3· Children's Oncology Group· Source
Contact: Andrew J. Galligan (principal investigator)
Active, not recruiting
Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
NCT04928599· Children's Oncology Group· Source
Recruiting
Physio-Anatomy Clinical Data Collection Study
NCT05312164· Gentuity, LLC· Source
Contact: Thanh Tran
Active, not recruiting
Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
NCT04759586· Phase 3· National Cancer Institute (NCI)· Source
Active, not recruiting
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
NCT05050136· Phase 2· Mirum Pharmaceuticals, Inc.· Source

Showing 50 of 96.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Childhood cancers11 recruiting
Heart failure6 recruiting
Colorectal cancer5 recruiting
Ovarian cancer4 recruiting
Stroke4 recruiting
Coronary artery disease3 recruiting
Head and neck cancer3 recruiting
Myeloproliferative neoplasms3 recruiting
Acute lymphoblastic leukaemia2 recruiting
Acute myeloid leukaemia2 recruiting
Aortic aneurysm2 recruiting
Brain aneurysm2 recruiting
Kidney cancer2 recruiting
Neuroendocrine tumours2 recruiting
Pancreatic cancer2 recruiting
Sarcoma2 recruiting
Alzheimer disease1 recruiting
Atrial fibrillation1 recruiting
Cervical cancer1 recruiting
Cystic fibrosis1 recruiting
Down syndrome1 recruiting
Endometrial cancer1 recruiting
High blood pressure1 recruiting
HIV1 recruiting
Liver cirrhosis1 recruiting
Lung cancer1 recruiting
Meningioma1 recruiting
Myelodysplastic syndromes1 recruiting
Peripheral artery disease1 recruiting
Pulmonary arterial hypertension1 recruiting
Triple-negative breast cancer1 recruiting

Closed trials

Withdrawn
Improving Access to Renal Transplantation for Underserved Black Communities
NCT06707038· Northwestern University· Source
Completed
A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning (USF)
NCT06705439· Neuro Event Labs Inc.· Source
Completed
SafeHeal Diverting Ileostomy Pivotal Study
NCT06152276· SafeHeal Inc· Source
Completed
Study of DF6215 in Patients With Advanced Solid Tumors
NCT06108479· Phase 1· Dragonfly Therapeutics· Source
Terminated
Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®
NCT05900050· Phase 2· Genfit· Source
Completed
Impella Real-World Surveillance of Patients Using Sodium Bicarbonate
NCT05820451· Abiomed Inc.· Source
Completed
Abbott i-STAT High Sensitivity Troponin I Study
NCT05629572· Abbott Point of Care· Source
Completed
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
NCT05383872· InSightec· Source
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
NCT04831580· GOG Foundation· Source
Contact: Sarin Chhab
Completed
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
NCT05014672· Phase 2· Calliditas Therapeutics Suisse SA· Source
Completed
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
NCT06378632· Cordio Medical· Source
Terminated
SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study
NCT05010850· SafeHeal Inc· Source
Completed
A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome
NCT06734117· Hoffmann-La Roche· Source
Completed
SURPASS Impella 5.5 Study
NCT05100836· Abiomed Inc.· Source
Completed
REal-World Analyses of Stroke - Thrombus Occlusion REtrieval
NCT04451525· Microvention-Terumo, Inc.· Source
Completed
Multi-arm Optimization of Stroke Thrombolysis
NCT03735979· Phase 3· Washington University School of Medicine· Source
Completed
SVC Occlusion in Subjects With Acute Decompensated Heart Failure
NCT03836079· Abiomed Inc.· Source
Completed
Sleep for Stroke Management and Recovery Trial
NCT03812653· University of Michigan· Source
Completed
Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundle Branch Block
NCT03803995· Abbott Medical Devices· Source
Terminated
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma
NCT03530683· Phase 1· Pfizer· Source
Completed
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer
NCT03223753· Phase 3· Children's Oncology Group· Source
Completed
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis
NCT03183245· Phase 3· Humacyte, Inc.· Source
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
NCT02914535· Phase 3· Alfasigma S.p.A.· Source
Terminated
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation
NCT02928497· Boston Scientific Corporation· Source
Completed
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
NCT02717507· Phase 2· Children's Oncology Group· Source
Completed
Zenith® p-Branch® Endovascular Graft Pivotal Study
NCT02396199· Cook Research Incorporated· Source
Completed
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
NCT01503086· Children's Oncology Group· Source
Completed
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
NCT01979536· Phase 2· National Cancer Institute (NCI)· Source
Completed
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
NCT01793233· Children's Oncology Group· Source
Completed
BAROSTIM NEO Hypertension Pivotal Trial
NCT01679132· CVRx, Inc.· Source
Completed
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
NCT01602666· Phase 2· Children's Oncology Group· Source
Completed
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
NCT02883049· Phase 3· National Cancer Institute (NCI)· Source
Completed
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
NCT01503632· Phase 3· Children's Oncology Group· Source
Completed
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT01371981· Phase 3· National Cancer Institute (NCI)· Source
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
NCT01190930· Phase 3· Children's Oncology Group· Source
Completed
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET
NCT00392327· Phase 3· Children's Oncology Group· Source
Completed
Collecting and Storing Tissue From Young Patients With Cancer
NCT00898755· Children's Oncology Group· Source
Completed
Study of Kidney Tumors in Younger Patients
NCT00898365· Children's Oncology Group· Source
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
NCT00904241· Children's Oncology Group· Source

Site data: ClinicalTrials.govUpdated 14 Nov 2026

Report an error